Beijing Key Laboratory of Environmental Toxicology, School of Public Health, Capital Medical University, Beijing, 100069, P. R. China.
Department of Oncology, Capital Medical University, Beijing, 100069, P. R. China.
Adv Sci (Weinh). 2022 Dec;9(35):e2202116. doi: 10.1002/advs.202202116. Epub 2022 Oct 28.
The Epstein-Barr virus (EBV) genome encodes a cluster of 22 viral microRNAs, called miR-BamHI-A rightward transcripts (miR-BARTs), which are shown to promote the development of cancer. Here, this study reports that EBV-miR-BART18-3p is highly expressed in colorectal cancer (CRC) and is closely associated with the pathological and advanced clinical stages of CRC. Ectopic expression of EBV-miR-BART18-3p leads to increased migration and invasion capacities of CRC cells in vitro and causes tumor metastasis in vivo. Mechanistically, EBV-miR-BART18-3p activates the hypoxia inducible factor 1 subunit alpha/lactate dehydrogenase A axis by targeting Sirtuin, which promotes lactate accumulation and acetyl-CoA production in CRC cells under hypoxic condition. Increased acetyl-CoA utilization subsequently leads to histone acetylation of fatty acid synthase and fatty acid synthase-dependent fat synthesis, which in turn drives de novo lipogenesis. The oncogenic role of EBV-miR-BART18-3p is confirmed in the patient-derived tumor xenograft mouse model. Altogether, the findings define a novel mechanism of EBV-miR-BART18-3p in CRC development through the lipogenesis pathway and provide a potential clinical intervention target for CRC.
EB 病毒(EBV)基因组编码了一簇 22 个病毒 microRNAs,称为 miR-BamHI-A 右向转录物(miR-BARTs),这些 microRNAs 被证明可以促进癌症的发展。本研究报告称,EBV-miR-BART18-3p 在结直肠癌(CRC)中高度表达,并且与 CRC 的病理和晚期临床阶段密切相关。EBV-miR-BART18-3p 的异位表达导致 CRC 细胞体外迁移和侵袭能力增加,并导致体内肿瘤转移。在机制上,EBV-miR-BART18-3p 通过靶向沉默调节蛋白(Sirtuin)激活缺氧诱导因子 1 亚基α/乳酸脱氢酶 A 轴,在缺氧条件下促进 CRC 细胞中乳酸的积累和乙酰辅酶 A 的产生。增加的乙酰辅酶 A 利用率随后导致脂肪酸合成酶的组蛋白乙酰化和脂肪酸合成酶依赖性脂肪合成,从而推动从头脂肪生成。EBV-miR-BART18-3p 的致癌作用在患者来源的肿瘤异种移植小鼠模型中得到了证实。总之,这些发现通过脂肪生成途径定义了 EBV-miR-BART18-3p 在 CRC 发展中的新机制,并为 CRC 提供了一个潜在的临床干预靶点。